Children who have severe and persistent juvenile idiopathic arthritis (JIA), during or even after treatment, may be considered for therapies that have been proved to be safe and effective for adult rheumatoid arthritis or other autoimmune disease but have yet to be fully studied for juvenile idiopathic arthritis. Examples of such therapies include:
Giannini EH, Brunner HI (2005). Treatment of juvenile rheumatoid arthritis. In WJ Koopman, LW Moreland, eds., Arthritis and Allied Conditions, 15th ed., vol. 1, pp. 1301-1318. Philadelphia: Lippincott Williams and Wilkins.
Weiss JR, Ilowite NT (2005). Juvenile idiopathic arthritis. Pediatric Clinics of North America, 52(2): 413-442.
ByHealthwise StaffPrimary Medical ReviewerSusan C. Kim, MD - PediatricsBrian O'Brien, MD, FRCPC - Internal MedicineMartin J. Gabica, MD - Family MedicineE. Gregory Thompson, MD - Internal MedicineKathleen Romito, MD - Family MedicineSpecialist Medical ReviewerJohn Pope, MD, MPH - Pediatrics
Current as ofOctober 10, 2017
Current as of: October 10, 2017
Susan C. Kim, MD - Pediatrics
& Brian O'Brien, MD, FRCPC - Internal Medicine & Martin J. Gabica, MD - Family Medicine & E. Gregory Thompson, MD - Internal Medicine & Kathleen Romito, MD - Family Medicine & John Pope, MD, MPH - Pediatrics
To learn more about Healthwise, visit Healthwise.org.
© 1995-2018 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.